Crossmark

Repurposing approved drugs as potential inhibitors of Mycobacterium tuberculosis ClpP: Structure-based virtual screening, molecular dynamics, and in vitro evaluation

Crossref DOI link: https://doi.org/10.1007/s11030-025-11452-8

Published Online: 2026-01-14

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bhardwaj, Smriti https://orcid.org/0009-0007-5454-4520
Roy, Kuldeep K. https://orcid.org/0000-0001-9623-0617
Funding

Funding for this research was provided by:

Science and Engineering Research Board (SRG/2021/001734)
License Information

Text and Data Mining valid from 2026-01-14

Version of Record valid from 2026-01-14
More Information

Article History

Received: 22 November 2025

Accepted: 22 December 2025

First Online: 14 January 2026

Declarations

:

: The authors declare that they have no known competing interests.

Document is current

Any future updates will be listed below